Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer

BACKGROUND: Aberrant patterns of microRNA expression have been highlighted as a potential clinical biomarker in breast cancer as the most frequent cancer among women that contributes nearly a quarter of total cancer incidence in 2018. Upregulation of microRNA-21 (miR-21) is associated with adverse c...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Sumadi Lukman, Sari, Dwi Nur Indah, Kartika, Aprilia Indra, Fitria, Meutia Srikandi, Tanjung, Dewi Sahfitri, Rakhmina, Dinna, Wardana, Tirta, Astuti, Indwiani, Haryana, Sofia Mubarika, Aryandono, Teguh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948877/
https://www.ncbi.nlm.nih.gov/pubmed/31030498
http://dx.doi.org/10.31557/APJCP.2019.20.4.1223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948877/
https://www.ncbi.nlm.nih.gov/pubmed/31030498
http://dx.doi.org/10.31557/APJCP.2019.20.4.1223

Ejemplares similares